{"cdcTestId":"2022-0005","testcaseName":" Patient is 6 years of age and is administered Jansen as dose #1 and Pfizer as dose #2. ","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2016-09-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-09T00:00:00","recommendedDate":"2022-11-09T00:00:00","pastDueDate":"2022-12-13T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-10-19T12:14:13.095","generalDescription":"This test case describes when a patient that is 6 years of age and is administered the Janssen Covid-19 vaccine as a first dose and Pfizer Covid-19 vaccine as the second dose, that the first dose is not valid.  Another dose should be forecast.","changedInVersion":"4.26","reasonForChange":"v4.26 Updated vaccine dose status from \u0022valid\u0027 to \u0022not valid\u0022 based on current Covid-19 Clinical Consideration guidelines comments, found in Table C.\nv4.23 Updated the test case based on new updated ACIP Guideline Recommendations (05/19/22) that expands the eligibility for a booster dose for children ages 5-11 years, 5 months after the second dose."}